Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-01-08 @ 6:53 AM
Study NCT ID:
NCT00460460
Status:
TERMINATED
Last Update Posted:
2011-01-25
First Post:
2007-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D2782C00002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None